Beryllium, Blood
Use
This test is utilized for the detection of beryllium exposure in individuals. It measures the concentration of beryllium in blood, which is critical for evaluating exposure to this element, commonly used in industries such as aerospace, electronics, and telecommunications. Monitoring is essential for preventive health measures and ensuring workplace safety, particularly for workers in occupations with potential exposure to beryllium dust or fumes.
Special Instructions
When collecting the specimen, use a metal-free, royal blue-top with EDTA tube to avoid contamination that may affect test results. Ensure the blood sample is refrigerated promptly to maintain specimen stability and ensure accurate testing.
Limitations
Analytical limitations may include interference from hemolysis, lipemia, or icterus in the blood sample. While inductively coupled plasma/mass spectrometry (ICP-MS) is a highly sensitive method for detecting trace metals, improper sample handling or contamination can lead to inaccurate results. Specimen validity is crucial for reliable outcomes, and adherence to specified stability conditions is necessary to prevent degradation of the analyte.
New York Approved
Methodology
Mass Spectrometry (ICP-MS)
Biomarkers
LOINC Codes
- 8159-6
- 8159-6
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
2 mL
Minimum Volume
0.3 mL
Container
Metal-free, royal blue-top with EDTA tube
Collection Instructions
Draw blood in a metal-free, royal blue-top with EDTA tube(s). Send 2 mL of EDTA whole blood refrigerated.
Storage Instructions
Refrigerate specimen immediately after collection. Sample is stable for 14 days refrigerated, 72 hours ambient, and 180 days frozen.
Causes for Rejection
Hemolysis, lipemia, icterus, or other unspecified issues.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 72 hours |
| Refrigerated | 14 days |
| Frozen | 180 days |